Aquarius Pharma Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.22 Cr
- Revenue Growth %
- Profit Growth 41.63%
- Ebitda 60.70%
- Net Worth -6.09%
- Total Assets -6.32%
About Aquarius Pharma Services
Aquarius Pharma Services Private Limited (APSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 2004 and has a history of 20 years and 11 months. Its registered office is in Delhi, India.
The Corporate was formerly known as Aquarius Pharma Private Limited.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.22 Cr.
Gopal Pandey and Samden Sherpa serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL2004PTC124479
-
Company No.
124479
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Feb 2004
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aquarius Pharma Services?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gopal Pandey | Director | 18-Feb-2015 | Current |
Samden Sherpa | Director | 18-Feb-2015 | Current |
Financial Performance of Aquarius Pharma Services.
Aquarius Pharma Services Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 41.63% increase in profit. The company's net worth dipped by a decrease of 6.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Aquarius Pharma Services?
In 2019, Aquarius Pharma Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹22.21 M
₹0
Charges Breakdown by Lending Institutions
- Punjab & Sind Bank : 1.52 Cr
- Punjab And Sind Bank : 0.70 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Feb 2011 | Punjab & Sind Bank | ₹1.41 M | Open |
11 Feb 2011 | Punjab & Sind Bank | ₹1.38 Cr | Open |
24 Mar 2007 | Punjab And Sind Bank | ₹4.50 M | Open |
24 Mar 2007 | Punjab And Sind Bank | ₹1.50 M | Open |
24 Mar 2007 | Punjab And Sind Bank | ₹1.00 M | Open |
How Many Employees Work at Aquarius Pharma Services?
Unlock and access historical data on people associated with Aquarius Pharma Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquarius Pharma Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquarius Pharma Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.